Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Violet N Chihota

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Plos One|September 19, 2015
Missed Opportunities for TB Investigation in Primary Care Clinics in South Africa: Experience from the XTEND TrialViolet N Chihota, Sibuse Ginindza, Kerrigan McCarthy, et al.
The Journal of Infectious Diseases|November 9, 2017
The South African Tuberculosis Care Cascade: Estimated Losses and Methodological ChallengesPren Naidoo, Grant Theron, Molebogeng X Rangaka, et al.
AIDS (London, England)|November 17, 2010
Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screeningGavin J Churchyard, Katherine L Fielding, James J Lewis, et al.
Pathogens (Basel, Switzerland)|November 11, 2022
Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis PatientsNicole Salazar-Austin, Christiaan Mulder, Graeme Hoddinott, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 1, 2015
Brief Report: The Effect of Antiretroviral Therapy and CD4 Count on Markers of Infectiousness in HIV-Associated TuberculosisClare L van Halsema, Katherine L Fielding, Violet N Chihota, et al.
Plos One|August 21, 2012
Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence surveySusan E Dorman, Violet N Chihota, James J Lewis, et al.
Plos One|November 19, 2013
Eligibility for isoniazid preventive therapy in South African gold minesJames J Lewis, Katherine L Fielding, Alison D Grant, et al.
AIDS (London, England)|March 20, 2010
Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence settingClare L van Halsema, Katherine L Fielding, Violet N Chihota, et al.
Plos One|March 3, 2018
Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South AfricaLiesl Page-Shipp, James J Lewis, Kavindhran Velen, et al.
Plos One|July 4, 2018
Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot studyNoriah Maraba, Christopher J Hoffmann, Violet N Chihota, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Plos One|September 19, 2015
Missed Opportunities for TB Investigation in Primary Care Clinics in South Africa: Experience from the XTEND TrialViolet N Chihota, Sibuse Ginindza, Kerrigan McCarthy, et al.
The Journal of Infectious Diseases|November 9, 2017
The South African Tuberculosis Care Cascade: Estimated Losses and Methodological ChallengesPren Naidoo, Grant Theron, Molebogeng X Rangaka, et al.
AIDS (London, England)|November 17, 2010
Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screeningGavin J Churchyard, Katherine L Fielding, James J Lewis, et al.
Pathogens (Basel, Switzerland)|November 11, 2022
Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis PatientsNicole Salazar-Austin, Christiaan Mulder, Graeme Hoddinott, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 1, 2015
Brief Report: The Effect of Antiretroviral Therapy and CD4 Count on Markers of Infectiousness in HIV-Associated TuberculosisClare L van Halsema, Katherine L Fielding, Violet N Chihota, et al.
Plos One|August 21, 2012
Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence surveySusan E Dorman, Violet N Chihota, James J Lewis, et al.
Plos One|November 19, 2013
Eligibility for isoniazid preventive therapy in South African gold minesJames J Lewis, Katherine L Fielding, Alison D Grant, et al.
AIDS (London, England)|March 20, 2010
Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence settingClare L van Halsema, Katherine L Fielding, Violet N Chihota, et al.
Plos One|March 3, 2018
Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South AfricaLiesl Page-Shipp, James J Lewis, Kavindhran Velen, et al.
Plos One|July 4, 2018
Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot studyNoriah Maraba, Christopher J Hoffmann, Violet N Chihota, et al.
Pageof 3